Celcuity (CELC) Cash from Operations (2016 - 2025)
Celcuity (CELC) reported Cash from Operations of 36399000.0 for Q4 2025, down 31.07% on a YoY basis from 52808120.27 in Q4 2024, and up 18.78% quarter-over-quarter from 44816000.0 in Q3 2025.
Celcuity (CELC) Cash from Operations (2016 - 2025) Analysis & Trends
Celcuity has reported Cash from Operations for 10 years, with the latest figure at 36399000.0 in Q4 2025.
- For the quarter ending Q4 2025, Cash from Operations fell 31.07% year-over-year to 36399000.0; the trailing twelve-month figure through Dec 2025 stood at 153280000.0 (down 83.64% YoY), and the FY2025 full-year result was 153280000.0, down 83.64% from the prior year.
- Cash from Operations for Q4 2025 stood at 36399000.0, up from 44816000.0 in the prior quarter.
- The five-year high for Cash from Operations was 2521505.0 in Q1 2021, with the low at 44816000.0 in Q3 2025.
- Historically, Cash from Operations has averaged 17343968.2 across 5 years, with a median of 12807140.0 in 2023.
- Annual changes were most pronounced in 2021 — Cash from Operations slumped 389.56% — and 2023, when it increased 14.41%.
- Celcuity's Cash from Operations stood at 6124002.0 in 2021, then plunged by 54.79% to 9479260.0 in 2022, then plunged by 95.54% to 18535921.0 in 2023, then tumbled by 49.82% to 27770000.0 in 2024, then plunged by 31.07% to 36399000.0 in 2025.
- The last three Cash from Operations figures came in at 36399000.0 (Q4 2025), 44816000.0 (Q3 2025), and 36212000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -2.49 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Celcuity | 4.14 Bn | 3.42 Bn | - | -36.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -36.40 Mn |
| Dec 31, 2025 | -36.40 Mn |
| Sep 30, 2025 | -44.82 Mn |
| Sep 30, 2025 | -44.82 Mn |
| Jun 30, 2025 | -36.21 Mn |
| Jun 30, 2025 | -36.21 Mn |
| Mar 31, 2025 | -35.85 Mn |
| Mar 31, 2025 | -35.85 Mn |
| Dec 31, 2024 | -27.77 Mn |
| Dec 31, 2024 | -27.77 Mn |
| Sep 30, 2024 | -20.56 Mn |
| Sep 30, 2024 | -20.56 Mn |
| Jun 30, 2024 | -18.07 Mn |
| Jun 30, 2024 | -18.07 Mn |
| Mar 31, 2024 | -17.07 Mn |
| Mar 31, 2024 | -17.07 Mn |
| Dec 31, 2023 | -18.54 Mn |
| Dec 31, 2023 | -18.54 Mn |
| Sep 30, 2023 | -12.75 Mn |
| Sep 30, 2023 | -12.75 Mn |